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Summary 
The predominant peptides bound to major histocompatibility complex class II molecules expressed 
on human B cells are derived from a relatively limited number of self proteins.  To determine 
whether any of the prebound self peptides might be released in endosomes during recycling, 
water-soluble HLA-DR1 molecules were incubated with a high affinity synthetic peptide at pH 
4.0 and 7.0 at 37~  The resulting bound peptide repertoire was then acid extracted, and separated 
by reversed-phase high  performance liquid  chromatography.  Using  a  combination  of mass 
spectrometry and ultraviolet spectroscopy, prebound self peptides and newly bound synthetic 
peptide were characterized. Most self peptides bound to HLA-DR1 were not appreciably released 
during extended exposure to pH 4.0. However, some invariant chain-derived peptides were uniquely 
released at this pH. 
T 
he majority of peptides bound by MHC class II molecules 
during antigen loading are not derived from ingested 
and processed foreign proteins, but instead are primarily de- 
rived from a finite number of self proteins (1,  2).  During 
progression outward through the exocytic pathway, dass II-in- 
variant chain (Ii) complexes are exposed to a decreasing pH 
gradient reaching a lower limit of 4.5-5.5 (for a review see 
reference 3). However, the exact organelles (and resulting pH) 
where Ii is proteolytically removed and peptide binding ensues 
are not well understood and peptide binding may occur in 
multiple intracellular compartments depending on the source 
protein and the site of its proteolysis. 
The effect of pH on class II-peptide interaction in vitro 
is highly dependent on the class II molecule, the peptide, 
and the method employed for the analysis.  In general, the 
on rate (kon) for many peptides is measurably increased as 
the pH is lowered from 7 to 4 but the off rate (koff) is not 
as dramatically changed (4-10). 
Substantial insight into the specificity and affinity of class 
II-peptide interaction has been obtained by way of in vitro 
binding assays, but whether particular families of peptides 
or small amounts of many different individual peptides are 
exchanged during these peptide binding experiments has re- 
mained unknown. To address these questions, water soluble 
HLA-DR1 molecules purified from human B cells (the use 
of which avoids the secondary effects due to detergent) have 
been produced. A combination of reversed-phase chromatog- 
raphy (RPC) and mass spectrometry was used to closely scru- 
tinize the influence of acid pH on class U-bound self peptides 
and peptide exchange. 
Materials and Methods 
Purification of Water-soluble HLA-DR1.  HLA-DR1  (DRA1/ 
DRBI*0101) was immunoaffinity purified from the Epstein-Barr- 
transformed homozygous human B cell line LG-2 then proteolyti- 
cally digested with papain as previously described (11), but after 
digestion the procedure was modified as follows. The papain/HLA- 
DK mixture was dialyzed for 12 h at 4~  against distilled water 
(12-14 kD exclusion tubing;  GIBCO BRL, Gaithersburg, MD), 
then sedimented at 40,O00g for 1 h (pelleting a substantial fraction 
of the total papain and any undigested HLA-DR molecules). The 
40,000 g supernatant fraction was adjusted to 50 ml with a final 
concentration of  2% ampholytes  (Biolytes  pH 3-10; Bio-Rad Labora- 
tories, Richmond, CA). The sample  was then subjected to prepara- 
tive isoelectric focusing (PIEF; Rotofor, Bio-Rad Laboratories) for 
5 h at 4oC using a constant power setting of 12 W. The focused 
fractions were harvested by vacuum aspiration and an aliquot of 
each to measure the pH and protein content. Samples containing 
purified HLA-DR1  were pooled and differentially treated as de- 
scribed below. Using PIEF, and an ampholyte gradient from pH 
3-10, water soluble class II molecules were separated from con- 
taminating papain and focused to a region ofpH 4.0-5.0 over the 
course of 5 h at 40C. PIEF had no detectable effect on the stability 
of HLA-DR dimers and, in fact, PIEF-purified material crystal- 
lized with similar crystal morphology as material purified without 
the use of PIEF (12, and Brown, J., personal communication). 
Exposure of  HLA-DRI to Acidic  pH.  After PIEF, fractions con- 
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dialysis tubing and dialyzed against 20 mM 2-(N-morpholino) 
ethanesulfonic  acid (MES), pH 5.0, for 48 h at 4~  to remove am- 
pholytes. After dialysis,  the sample was divided into two equal frac- 
tions and each placed  into a 25-kD exclusion  vacuum dialysis  collo- 
dion membrane (Schleicher & Schuell, Inc., Keene, NH). One 
sample was vacuum dialyzed/concentrated to 1 ml against citrate 
buffer, pH 4.0, and the other sample was vacuum dialyzed/con- 
centrated to I ml against MES, pH 7.0, both at 4~  Each sample 
was again divided into two equal fractions and all four samples 
placed into 1-kD exclusion  dialysis  tubing (Spectra/Por 1,000; Spec- 
trnm Medical Industries, Inc., Houston, TX). To one pH 4.0 and 
one pH 7.0 sample, a synthetic peptide derived from .the human 
Ig  K chain was  added (50  /~M; residues 188-202; KHKVYA- 
CEVTHQGLS), but to the two other samples  no peptide  was added. 
The two pH 4.0 and the two pH 7.0 samples were placed into 
vesicles containing prewarmed  citrate buffer (pH 4.0) and MES (pH 
7.0), respectively,  and all samples were maintained at 37~  for 24 
h. HLA-DR1 molecules  were then repurified  by HPLC-size exclu- 
sion chromatography (HPLC-SEC)  in 20 mM MES, pH 6.5 (BIO- 
SIL TSK-250; Bio-Rad Laboratories). 
Analysis of HLA-DR Bound  Peptide  Repertoire.  Peptides  were ex- 
tracted and separated  by R.PC as previously  described (1). To deter- 
mine a precise retention time, 25 pmol of the K  synthetic peptide 
188-202 was subjected to the identical RPC gradient conditions 
used for the total extracted pools. The peptide repertoire present 
in each RPC fraction  was determined  by matrix-assisted  laser desorp- 
tion mass spectrometry (MALDI-MS, Lasermat; Finnigan MAT, 
San Jose, CA) (2). Briefly,  RPC fractions were concentrated to 25 
~1 and applied to autosampler targets using 2/~1 of sample and 
0,4/zl of matrix. An internal standard was used to calculate exact 
mass assignments. 
Results  and  Discussion 
To determine whether any of the predominant peptides 
in the HLA-DR1 repertoire were preferentially released at 
pH 4.0, the following experiments were performed. First, 
the difficulties associated with the presence of detergent were 
eliminated by digesting HLA-DR1 molecules with papain 
to remove the transmembrane domain and cytoplasic  tail. 
Water-soluble class II molecules were then adjusted to pH 
4.0 and 7.0 and incubated at 37~  in the presence or absence 
of synthetic peptide derived from the Igx L chain (known 
to bind HLA-DR1; 2). After 24 h, HLA-DR-peptide com- 
plexes were separated from free peptide by HPLC-SEC and 
the MHC bound peptides acid extracted, then separated by 
microbore RPC (Fig.  1). 
The remarkable similarity  between the pH 7.0 and 4.0 chro- 
matograms indicates that in weak acid,  little or no release 
of most prebound peptides occurs and that microbore RPC 
of  these complex peptide mixtures is highly reproducible (Fig. 
1, a and c). Although each individual chromatographic peak 
represents a mixture of multiple peptides when RPC is used 
coordinately with MS, the relative amount of each individual 
peptide present can be determined. Close inspection indicated 
that all four chromatographic peaks  containing the nested 
set of Ii-derived peptides (Fig.  1, peaks 6-9) were reduced 
after exposure to acidic pH, but each peak was known to 
contain multiple peptides (1). In addition, not all the Ii- 
containing peaks were equally affected (compare Fig. 1, a and 
b). To determine if particular Ii-derived peptides were sensi- 
tive to acidic pH, comparative MS was performed on these 
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Figure  1.  lkPC peptide profiles from 
pH-treated and non-pH-treated  I-ILA-DR1 
molecules. Chromatograms are  plotted 
from 30 to 83 min with a full-scale UV 
absorption  at 210 and 277 nm of 125 mAU. 
(c) The predominant  peptides  in the labeled 
peaks are as follows: 1. Bovine  fetuin 56- 
74, YKI-ITLNQIDSVKVWPRRP;  2. Bo- 
vine fetuin 56-73, YKI-ITLNQIDSVK- 
VWPRR; 3. Na+/K + ATPase 199-216, 
IPADLRIISANGCKVDNS;  3. HLA-A2- 
like 104-117, GSDWRFLILGYHQYA;  3. 
HLA-A2-1ike 105-117, SDWILFLIkGY- 
HQYA; 4. Transferrin receptor 680-6%, 
RVEYHFLSPYVSPKESP; 4.  HLA-A2- 
like 103-117, VGSDWRFLRGYHQYA;  4. 
HLA-A2-1ike 103-116, VGSDWILFLR- 
GYHQY; 5. HLA-A2-1ike  103-120, VGS- 
DWIkFLRGYHQYAYDG;  and 6-9. 11 Ii 
peptides spanning  97-121, LPKPPKFVSK- 
MRMATPLLMQALPMG. 
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Peak  Pept  ide  Length  Observed  Calculated  pH 
Number  Sequence  Mass  Mass  Sens  it  ivi  ty 
(dalcons)  (dalCons) 
1  KPPKPVSKMRMATPLLMQALP  21  2335.2  2334.9  + 
2  pKPPKPVSIq4RMATPLLMQALP  22  2433.2  2432.0  * 
3  KMRMATPLLMQALp  14  1601.0  1601.0 
4  LPKPPKPVSKMRMATPLLMQALP  23  2545.2  2545.2  § 
5  KMRMATPLLMQALPM  15  1732.7  1732.2 
6  PKPPKPVS~4ATPLLMQALPM  23  2562.1  2563.2  + 
7  LpKPPKPVSKMRMATPLLM(IqLPM  24  2675.3  2676.4  § 
Figure 2.  MALDI-MS  analysis 
of Ii-derived peptides. Fractions 68- 
89, 70-71, and 72-73 were pooled 
and peptides present in each sample 
identified  by MALDI-MS as  de- 
scribed in Materials and Methods. 
The previously identified li-derived 
peptides (1) are numbered in each 
spectra and listed in the table at the 
bottom. 
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peptides that contained residues 99-105 were markedly released 
by exposure to acidic pH, whereas those that lacked this re- 
gion were not. Little or no release of these Ii-derived pep- 
tides was observed if the experiment was performed at room 
temperature (data not shown). Using HLA-DR3-Ii peptide 
complexes purified from the cell line T2 which is defective 
in antigen presentation, release of the Ii-derived peptides was 
obtained at low pH,  enabling the HLA-DR3  molecule to 
bind exogenous peptide (13).  It is interesting to note that 
in these studies all the prebound peptides were derived from 
Ii and all contained residues 99-105 in addition to the core 
residues (13, 14). The cellular origin of these complexes con- 
taining the long Ii peptides, i.e., intracellular or cell surface, 
is presently unknown. It seems possible that the 99-105 re- 
gion of full-length Ii is also involved in the acid-induced dis- 
sociation of Ii-class II complexes in endosomes. 
Treatment at pH 4 was also performed in the presence of 
a high affinity exogenous peptide derived from Ig K chain 
(2). A unique peak was seen in the pH 4/peptide (+) profile 
at 42 min (Fig.  1, d),  not found in the pH 4/peptide (-) 
profile (Fig. I b). Comparison of this peak to the RPC chro- 
matographic analysis of the purified synthetic K  peptide eluted 
under the same conditions, confirmed that both had iden- 
tical retention times and spectral ratios (210, 277, and 292 
nm).  Although  exact  quantitation  was  not  possible,  the 
amount of ~ bound was approximately equal to the sum of 
Ii peptide that had been released. A small unique peak (unla- 
beled) was also seen in the control pH 7/peptide (+) sample 
at 42 min (Fig. I c). From these data it is evident that binding 
of the K peptide to HLA-DR1 molecules was enhanced at 
pH 4.  These observations have two possible  explanations: 
(a) the affinity of the K peptide is substantially increased at 
acidic pH,  or (b) the increase in the available binding sites 
at acidic pH (largely attributable to the release of the long-Ii 
peptides) resulted in the higher levels of g peptide binding. 
Additionally, it should be noted that reduction of peaks 6 
and 8 after exposure to acidic pH was not enhanced or "cata- 
lyzed" by the presence of a large excess of exogenously added 
peptide (15). 
To  verify that  the unique  peak  at  42  min  in  the pH 
treated/peptide (+) RPC profile indeed represented bound 
K peptide, MALDI-MS was performed on fractions spanning 
this time region in both the peptide (-) and peptide (+) 
profiles.  A  unique mass (1,700  m/z) corresponding to the 
peptide was found only in the peptide (+) and not in the 
peptide (-) sample (data not shown). In addition, a new mass 
of 3,398 m/z was also found in significant quantities in frac- 
tion 42.  Because the g peptide contains an internal cysteine 
(position 7 of the 15 residue peptide), a disulfide-linked dipep- 
tide was suspected. When the RPC fractions were reduced 
with 2/~-ME (2-ME) before MS a mass of 1,778 m/z, corre- 
sponding to the reduced peptide with a 2-ME adduct was 
detected concomitant with a dramatic reduction in the amount 
of the 3,398 m/z peak supporting the presence of disulfide- 
linked ~ peptides. 
Whether MHC class II molecules, like many others, are 
constitutively recycled is unclear. Some studies would pre- 
dict up to 60 recycling events occur during the lifetime of 
a class II molecule (16-19)  whereas other reports detect no 
recycling (20-23).  Because most studies have employed ei- 
ther pharmacologic strategies to block normal membrane 
trafficking and/or antibody tagging of surface receptors, cross- 
comparison of the data is difficult. Recently, L cell transfec- 
tants expressing MHC class II molecules and cytoplasmic tail 
deletion mutants of Ii have demonstrated that surface-expressed 
class II-Ii complexes can reenter endosomes, remove bound 
Ii and class II-peptide complexes return to the cell surface 
(24). However, the ability of surface class II molecules to reenter 
the endocytic pathway and then return to the cell surface may 
well be dependent on the species and/or cell type used. In 
cases where surface-expressed class II molecules do reenter 
the endocytic pathway, a fundamental obstacle of productive 
recycling is the slow dissociation of prebound peptides. The 
data presented here clearly demonstrate that exposure to pH 
4 alone does not increase the release of most prebound pep- 
tides from class II complexes and is in agreement with data 
obtained by others. However, this pH does enhance the re- 
lease of some Ii-derived peptides. In cases where a substantial 
fraction of the class II population contains Ii peptides (HLA- 
DR1 for example) this fraction might provide a means by 
which class II molecules reentering the endocytic pathway 
from the cell surface could exchange prebound Ii-derived pep- 
tides with peptides derived from other source proteins. How- 
ever, the kinetic basis for such an exchange system has yet 
to be demonstrated. Moreover, the selective chemical release 
of Ii peptides at pH 4 in vitro examined here does not ex- 
clude the possibility that conditions or proteins present in 
endosomes in vivo might facilitate the release of Ii or other 
peptides bound to MHC class II molecules. 
MHC-peptide binding studies have reached a new techno- 
logical level. Not only can the amount of newly bound pep- 
tide be determined but  the influence, if any,  that  the ex- 
ogenously added peptide had on the preexisting peptide-class 
II complexes can be determined (compare references 15 and 
25). For example, in the present study, most of the K  peptide 
binding was attributed to the replacement of prebound long-Ii 
peptides. In other MHC allotypes, with their distinct pre- 
bound peptide repertoires, other prominent self peptides may 
be specifically replaced. In fact, the outcome of these types 
of processes may help to explain why different class II allo- 
types bind different amounts of exogenously added peptide 
at equilibrium. 
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